← Open Payments lookup

SHERRI ASBEL: Open Payments

NPI 1073047643 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$853 in 46 payments from 14 companies in 2025. Trend: 2023 $329 · 2024 $245 · 2025 $853

Food & beverage: $853
CompanyPaymentsAmount
ABBVIE INC.14$224
Janssen Biotech, Inc.5$97
GENZYME CORPORATION4$81
Takeda Pharmaceuticals U.S.A., Inc.4$73
Madrigal Pharmaceuticals3$71
Ipsen Biopharmaceuticals, Inc3$63
Gilead Sciences, Inc.3$58
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$49
Intercept Pharmaceuticals, Inc.2$31
Regeneron Healthcare Solutions, Inc.1$27

Products named: DUPIXENT, CREON, TREMFYA, ENTYVIO, REZDIFFRA, IQIRVO, MAVYRET, XIFAXAN.

Industry payments across GA — which companies pay providers there.